Epigenetic silencing <i>L3MBTL4</i> sensitizes esophageal cancer to DNA-PKcs inhibitor

<i>L3MBTL4</i> is a potential tumor suppressor and methylation of <i>L3MBTL4</i> is a sensitive marker of DNA-PKcs inhibitors.

Institutions

Publication Details

Journal
Cancer Biology & Therapy
Published
2026-03-24
DOI
https://doi.org/10.1080/15384047.2026.2646393
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Epigenetic silencing L3MBTL4 sensitizes esophageal cancer to DNA-PKcs inhibitor

Cancer Biology & Therapy
Acute Myeloid Leukemia Research
article

Epigenetic silencing L3MBTL4 sensitizes esophageal cancer to DNA-PKcs inhibitor

article en

Abstract

<i>L3MBTL4</i> is a potential tumor suppressor and methylation of <i>L3MBTL4</i> is a sensitive marker of DNA-PKcs inhibitors.

Cancer Biology & TherapyVol. 27(1)
Chinese University of Hong Kong (HK), Chinese PLA General Hospital (CN), Zhengzhou University (CN), Henan Medical University (CN)
Openalex Percentile: Top 11%
Acute Myeloid Leukemia Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Epigenetic silencing <i>L3MBTL4</i> sensitizes esophageal cancer to DNA-PKcs inhibitor · Cancer Biology & Therapy (2026) | TGRS Research Map | TGRS